ask="12.3000"
ask_size="1000"
average_daily_volume="26905"
bid="7.8500"
bid_size="200"
book_value="3.3400"
change="-0.0301"
change_from_200_day_moving_average="3.9880"
change_from_50_day_moving_average="1.9689"
change_from_52_week_high="-0.2201"
change_From_52_week_low="7.2599"
change_in_percent="-0.2785%"
close="10.7799"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.2620"
ebitda="-50.28M"
eps_estimate_current_year="-2.5400"
eps_estimate_next_quarter="-0.6000"
eps_estimate_next_year="-2.5700"
ex_dividend_date="N/A"
float_shares="N/A"
high="10.8500"
high_52_weeks="11.0000"
last_trade_date="2/28/2017"
last_trade_price="10.7799"
last_trade_size="100"
last_trade_time="3:59pm"
low="10.5000"
low_52_weeks="3.5200"
market_capitalization="229.40M"
moving_average_200_day="6.7919"
moving_average_50_day="8.8110"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="15.8100"
open="10.8000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+58.7163%"
percent_change_from_50_day_moving_average="+22.3455%"
percent_change_from_52_week_high="-2.0009%"
percent_change_from_52_week_low="+206.2472%"
previous_close="10.8100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.2365"
price_per_sales="44.2369"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.7900"
stock_exchange="NMS"
symbol="NBRV"
volume="15154"
weeks_range_52="3.5200 - 11.0000"
